PAM2L
China,TNGlobal Q&A and Interviews,Biotech / MedTech,Features
Shenzhen-based PAM2L Biotechnologies plans new round of funding to expand capabilities
PAM2L Biotechnologies is one of the finalists of Fund At First Pitch at BEYOND Expo 2024.
August 30, 2024
Fujitsu and Paradigm test AI screening for Japan trials
November 20, 2026
MetaComp adds about $10M from Tether and Further
November 20, 2026
Fujitsu and Paradigm test AI screening for Japan trials
November 20, 2026
MetaComp adds about $10M from Tether and Further
November 20, 2026




